Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Vector bioprocessing
Guest Editor:
Franz Gerner, Chief Technology Officer at Excision BioTherapeutics
Franz Gerner
Chief Technology Officer at Excision BioTherapeutics
April 2022
Sponsors
Download full spotlight
Manufacturing of RCA-free adenoviral vectors
27 March 2022
Poster
Nico Scheer
Thinking big: the need for innovation in the production of lentivirus-based cell and gene therapies
23 April 2022
Expert Roundtable Video
Hanna Leinonen,
John Moscariello,
Lee Davies ,
Scott Cross,
Will Junker
Flexible & scalable solutions for AAV viral vector production using a templated platform
20 April 2022
Innovator Insight
Eva Fong
Clarification of recombinant adeno-associated virus (rAAV) & lentivirus from adherent culture
3 May 2022
Research Article
Rajeshwar Chinnawar,
Nicholas Marchand
Process development innovations to improve gene therapy manufacturing
Jessica Hilmoe, Technical Leads Manager, Manufacturing and Operations at MilliporeSigma
Michael Shen, Associate Director, Process Development at MilliporeSigma
21 April 2022
Webinar
Watch now
Manufacturing of RCA-free adenoviral vectors
N Scheer
27 March 2022
Poster
Read more
Thinking big: the need for innovation in the production of lentivirus-based cell and gene therapies
H Leinonen,
J Moscariello,
L
et al.
23 April 2022
Expert Roundtable Video
Watch now
Flexible & scalable solutions for AAV viral vector production using a templated platform
E Fong
20 April 2022
Innovator Insight
Read more
Clarification of recombinant adeno-associated virus (rAAV) & lentivirus from adherent culture
R Chinnawar,
N Marchand
3 May 2022
Research Article
Read more
Vector bioprocessing spotlight
F Gerner
2 May 2022
Foreword
Read more
Future trends in viral vector process & product development
R Krishna
27 April 2022
Viewpoint
Read more
Considerations for demonstrating comparability of AAV processes
L Giersch
25 April 2022
Viewpoint
Read more
Accelerating cell & gene therapy workflows with next-generation analytical tools
C Heger, PhD
24 April 2022
Innovator Insight
Read more
Applying an HPLC analytical platform for mRNA process monitoring
Nejc Pavlin, Project Manager in Process Analytics Development at BIA Separations
7 June 2022
21
Days
8
Hrs
11
Min
Webinar
Register
Adeno-associated virus process development: optimization & development of a scalable elution for polishing chromatography
D Martin
10 April 2022
Expert Insight
Read more
Detecting residual host cell DNA with Droplet Digital PCR technology
M White
10 April 2022
FastFacts
Read more
From cells to purified capsids: How to develop a scalable rAAV process
Åsa Hagner McWhirter, Principal Scientist at Cytiva
3 May 2022
Webinar
Watch now
Adeno-associated viral vector process development challenges in early research& preclinical study
A Saksule
30 March 2022
Expert Insight
Read more
Manufacturing considerations for viral and non-viral platform selection
Vladimir Slepushkin, Global Head of Manufacturing at MedTherapy Biotech
Aaron Noyes, Vice President of Development at Codiak Biosciences
Allison Hagerman, Vice President, Product Development, Oncolytics Biotech
Laurens Sierkstra, Senior Director, Business Leader, Purification at Thermo Fisher Scientific
10 May 2022
Webinar
Watch now
Exploring commercial upstream processing of AAV
H Rojas
27 March 2022
Interview
Read more
Removing technological barriers to efficient large-scale LV vector production
Rakel Lopez de Maturana, Qualified Person at VIVEbioTech
Emily Jackson-Holmes, Associate Product Manager at Thermo Fisher Scientific
Margherita Neri, Vector Process Development Manager at AGC Biologics
Steven G. Milian, Senior Staff Scientist (Process Sciences), Science & Technology Pharma Services Viral Vector Services at Thermo Fisher Scientific
Scott Jeffers, Gene Therapy Research and Process Development Leader at Redpin Therapeutics
26 April 2022
Webinar
Watch now
What does Plug-and-Play offer large-scale AAV manufacturing?
Margherita Neri, Vector process Development Manager at MolMed SpA
Claire Wartel-Weill, Director, Quality & Compliance at Polyplus-transfection
22 March 2022
Webinar
Watch now
Increasing productivity of IVT reaction using at-line monitoring by HPLC chromatography
Rok Sekirnik, Head Process Development for mRNA and pDNA at BIA Separations
12 April 2022
Webinar
Watch now
Discovery to manufacturing: A continuum
Audrey Chang, Executive Director Quality Control & Analytical Sciences at Charles River Laboratories
Tony Hitchcock, Technical Director at Charles River Laboratories, Inc
Brian Fry, Director, Sales - Biologics at Charles River Laboratories
5 April 2022
Webinar
Watch now
Flexible and scalable solutions for AAV viral vector production using a templated platform
Eva Fong, Principal Scientist, Virus and Gene Therapy Bioprocessing at MilliporeSigma
17 March 2022
Webinar
Watch now
A scalable lentiviral vector production system based on stable producer cell lines
Roy Bin Liu, Business Development Director at Eureka Bio
29 March 2022
Webinar
Watch now
×
Please enter your email to register
Register